ACM
ZURA icon

ADAR1 Capital Management’s Zura Bio ZURA Stock Holding History

ADAR1 Capital Management’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.75M Buy
630,403
+68,338
+12% +$413K 0.22% 94
2025
Q4 		$2.95M Sell
562,065
-90,089
-14% -$356K 0.22% 81
2025
Q3 		$2.82M Sell
652,154
-345,393
-35% -$621K 0.27% 66
2025
Q2 		$1.05M Sell
997,547
-1,803,637
-64% -$2.16M 0.16% 80
2025
Q1 		$3.61M Buy
2,801,184
+723,933
+35% +$1.14M 0.67% 44
2024
Q4 		$5.19M Sell
2,077,251
-1,693,398
-45% -$6.03M 1.04% 22
2024
Q3 		$15.3M Buy
+3,770,649
New +$14.1M 2.49% 10

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

ADAR1 Capital Management's ZURA Position: Q1 2026 in Review

ADAR1 Capital Management increased its Zura Bio (ZURA) stake by 12% in Q1 2026, buying an estimated $413K and bringing the position to 630,403 shares worth $3.75M. The position accounts for 0.22% of the portfolio, ranked #94.

ADAR1 Capital Management first reported a position in ZURA in Q3 2024 and has held it in 7 quarters since. The position peaked at $15.3M in Q3 2024. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • ADAR1 Capital Management held 630,403 shares of Zura Bio worth $3.75M as of Q1 2026.
  • ADAR1 Capital Management bought 68,338 Zura Bio shares in Q1 2026, an estimated $413K.
  • Zura Bio made up 0.22% of ADAR1 Capital Management's portfolio in Q1 2026, its #94 holding.
  • ADAR1 Capital Management first reported a position in Zura Bio in Q3 2024 and has held it in 7 quarters since.
  • ADAR1 Capital Management's Zura Bio position peaked at $15.3M in Q3 2024.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.